Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
70 pending office actions • 51 art units • 69 examiners • 0 of 70 (0%) have an AI response strategy ready • 87 patents granted in the last 365 days
The Arizona Board of Regents on Behalf of the University of Arizona manages 75 pending office actions in Biotechnology & Pharmaceuticals. These filings are dispersed across 47 distinct art units, which highlights the broad nature of the university's research. The prosecution is decentralized, with 73 distinct examiners reviewing the 75 active matters. This distribution across 73 examiners for 75 actions indicates that nearly every action is handled by a different individual, requiring a highly coordinated legal strategy.
KUMAR, PREETI is the busiest examiner for the university, handling 2 of the 75 pending office actions. This means that the distinct examiners are each responsible for only a single pending action in almost every case. The high count of 47 distinct art units indicates that the university's patent applications are being evaluated across a wide variety of specialized technical groups. For the practitioner, this requires managing 73 different examiner relationships across 47 distinct art units to advance the 75 pending office actions within the Biotechnology & Pharmaceuticals field. The diversity of 47 art units suggests a need for broad technical expertise.
Based on the USPTO statutory response window for each pending office action. 24 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 24 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 2 (3%) |
| §101 + other | 10 (14%) |
| §103 only | 18 (26%) |
| §112 only | 2 (3%) |
| Double-patenting only | 1 (1%) |
| Double-patenting + other | 3 (4%) |
| Multi-statute (no §101) | 34 (49%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KUMAR, PREETI | 2 | 31.9% | +43.7% |
| BOBISH, CHRISTOPHER S | 1 | 62.4% | +28.9% |
| CHAUDRY, MUJTABA M | 1 | 84.5% | +3.9% |
| AHMED, JAMIL | 1 | 82.0% | +15.3% |
| JACKSON, JAKIEDA R | 1 | 74.1% | +15.8% |
| GOMES, SRISTI DIVINA | 1 | 25.0% | -33.3% |
| ISMAIL, OMAR S | 1 | 91.2% | +10.0% |
| ALBERS, KEVIN S | 1 | 26.4% | +49.9% |
| ESPINOSA, CLAUDIA EDILMA | 1 | 50.9% | +57.7% |
| ALEXANDER, WILLIAM R | 1 | 87.9% | +6.4% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18877469 | QUANTUM RECEIVERS FOR ENTANGLEMENT ASSISTED CLASSICAL OPTICAL COMMUNICATIONS | ISMAIL, OMAR S | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17413468 | BARN DUST EXTRACT FOR THE PREVENTION AND TREATMENT OF DISEASES | BENAVIDES, JENNIFER ANN | 113d overdue |
| 17769992 | FORMULATIONS FOR TREATMENT OF VIBRIO INFECTIONS | PROSSER, ALISSA J | 88d overdue |
| 17777011 | SILICA SHELL ENCAPSULATED POLYAROMATIC-CORE MICROPARTICLES | SVEIVEN, MICHAEL CAMERON | 80d overdue |
| 17631653 | PHYTO-MEDIATED WASTEWATER TREATMENT BIOREACTOR (PWBR) | ROYCE, LIAM A | 49d overdue |
| 17634734 | OPTICAL DESIGN AND OPTIMIZATION TECHNIQUES FOR 3D LIGHT FIELD DISPLAYS | DRAPEAU, SIMEON PAUL | 46d overdue |
| 17442017 | ENVIRONMENTALLY-FRIENDLY DUST SUPPRESSANT POLYMER BLEND | KUMAR, PREETI | 32d overdue |
| 18265335 | COMPOSITIONS AND METHODS FOR INHIBITING M PRO PROTEASE ACTIVITY AND FOR PREVENTING AND TREATING SARS-COV-2 INFECTION | DAHLIN, HEATHER RAQUEL | 23d overdue |
| 18730490 | METHODS, SYSTEMS AND DEVICES FOR USING GREEN LIGHT FOR NEURODEGENERATIVE DISEASES AND OTHER CONDITIONS WITH INFLAMMATORY REPONSES | PORTER, JR, GARY A | 3d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17442017 | ENVIRONMENTALLY-FRIENDLY DUST SUPPRESSANT POLYMER BLEND | KUMAR, PREETI | 32d overdue |
| 18973590 | BRACING DEVICE FOR RESTORING NATURAL FOOT MOVEMENT TO FLAT FOOT DEFORMITY PATIENTS | ALBERS, KEVIN S | 27d |
| 18869591 | GLYCOSYLATED CYCLIC ENDOMORPHIN ANALOGS | ESPINOSA, CLAUDIA EDILMA | 27d |
| 19138974 | SHAPE MEMORY ALLOY-DRIVEN DOUBLE-HELICAL DUAL-VALVE-ACTION HYDRODYNAMIC DRIVE FOR SOFT ROBOTIC APPLICATIONS IN AQUEOUS ENVIRONMENTS | BOBISH, CHRISTOPHER S | — |
| 19110763 | COMPACT, HIGH-RESOLUTION SNAPSHOT HYPERSPECTRAL IMAGING WITH 3D PRINTED GLASS LIGHTGUIDE ARRAY | AHMED, JAMIL | — |
| 19051667 | ARTIFICIALLY INTELLIGENT DIALOG EVALUATION SYSTEM AND ASSOCIATED METHODS | JACKSON, JAKIEDA R | — |
| 18877469 | QUANTUM RECEIVERS FOR ENTANGLEMENT ASSISTED CLASSICAL OPTICAL COMMUNICATIONS | ISMAIL, OMAR S | — |
| 18719497 | DUST SUPPRESSANT COMPOSITION COMPRISING GLYCOLIPID | KUMAR, PREETI | — |
| Art Unit | Apps |
|---|---|
| 2872 | 4 |
| 1654 | 3 |
| 1658 | 3 |
| 3746 | 2 |
| 3791 | 2 |
| 1629 | 2 |
| 3796 | 2 |
| 1681 | 2 |
| 1761 | 2 |
| 1634 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19138974 | SHAPE MEMORY ALLOY-DRIVEN DOUBLE-HELICAL DUAL-VALVE-ACTION HYDRODYNAMIC DRIVE FOR SOFT ROBOTIC APPLICATIONS IN AQUEOUS ENVIRONMENTS | BOBISH, CHRISTOPHER S | 3746 | §102§103 | Non-Final OA | — | Pending | Jun 13, 2025 |
| 19080706 | SYSTEMS AND METHODS FOR OPTIMIZED REGULAR AND IRREGULAR SD-LDPC CODES FOR 50G-PON/100G-PON AND BEYOND | CHAUDRY, MUJTABA M | 2112 | §101 | Final Rejection | — | Pending | Mar 14, 2025 |
| 19110763 | COMPACT, HIGH-RESOLUTION SNAPSHOT HYPERSPECTRAL IMAGING WITH 3D PRINTED GLASS LIGHTGUIDE ARRAY | AHMED, JAMIL | 2877 | §103§112 | Non-Final OA | — | Pending | Mar 11, 2025 |
| 19051667 | ARTIFICIALLY INTELLIGENT DIALOG EVALUATION SYSTEM AND ASSOCIATED METHODS | JACKSON, JAKIEDA R | 3682 | §103 | Non-Final OA | — | Pending | Feb 12, 2025 |
| 18880002 | SENSOR SUSPENSION SYSTEM FOR SUPINE CO2 MONITORING | GOMES, SRISTI DIVINA | 3791 | §103§112 | Non-Final OA | — | Pending | Dec 30, 2024 |
| 18877469 | QUANTUM RECEIVERS FOR ENTANGLEMENT ASSISTED CLASSICAL OPTICAL COMMUNICATIONS | ISMAIL, OMAR S | 2635 | §103 | Non-Final OA | — | Pending | Dec 20, 2024 |
| 18973590 | BRACING DEVICE FOR RESTORING NATURAL FOOT MOVEMENT TO FLAT FOOT DEFORMITY PATIENTS | ALBERS, KEVIN S | 3786 | §102§103§112 | Final Rejection | 27d | Pending | Dec 09, 2024 |
| 18869591 | GLYCOSYLATED CYCLIC ENDOMORPHIN ANALOGS | ESPINOSA, CLAUDIA EDILMA | 1654 | §103 | Final Rejection | 27d | Pending | Nov 26, 2024 |
| 18869821 | POLARIZATION COMPENSATION FOR CORNER CUBE REFLECTOR | ALEXANDER, WILLIAM R | 2872 | §102§103 | Non-Final OA | — | Pending | Nov 26, 2024 |
| 18858053 | SHAPE MEMORY ALLOY TETHER SYSTEM | MIAN, SHAFIQ A | 3746 | §103§112 | Non-Final OA | — | Pending | Oct 18, 2024 |
| 18844645 | CALCIMYCIN AS ANTIFUNGALS | REILLY, SOPHIA JANE | 1627 | §103Other | Non-Final OA | — | Pending | Sep 06, 2024 |
| 18838780 | Fumaric Acid Esters, Inhalation Administration Methods, Pharmaceutical Uses and Compositions | MEYERS, ELIZABETH ANNE | 1617 | §102§103§112DP | Non-Final OA | — | Pending | Aug 15, 2024 |
| 18797123 | EDUCATION APPLICATION FOR RECOGNIZING EVIDENCE OF MENTAL DISORDERS BY RE-USING MACHINE LEARNING DATASETS | BAIG, SENIYA | 3715 | §101§102§103§112 | Non-Final OA | — | Pending | Aug 07, 2024 |
| 18796015 | SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF | SCHMITT, MICHAEL J | 1629 | DP | Non-Final OA | — | Pending | Aug 06, 2024 |
| 18835778 | SMALL MOLECULE PIM AND MTOR KINASE INHIBITOR AND METHODS OF USE THEREOF | ENGLISH, CONNOR KENNEDY | 1625 | §102§103§112 | Non-Final OA | — | Pending | Aug 05, 2024 |
| 18730412 | WAVELENGTH AND DIFFRACTIVE MULTIPLEXED EXPANSION OF FIELD OF VIEW FOR DISPLAY DEVICES | GAGNON, GRANT A | 2872 | §102§103 | Final Rejection | — | Pending | Jul 19, 2024 |
| 18778281 | OPTICAL WAVEGUIDE COMPONENTS POSSESSING HIGH NONLINEAR EFFICIENCY AND ADAPTIVE-PROFILE POLING PROCESS TO FABRICATE THE SAME | PETKOVSEK, DANIEL | 2874 | §102§112 | Non-Final OA | — | Pending | Jul 19, 2024 |
| 18730490 | METHODS, SYSTEMS AND DEVICES FOR USING GREEN LIGHT FOR NEURODEGENERATIVE DISEASES AND OTHER CONDITIONS WITH INFLAMMATORY REPONSES | PORTER, JR, GARY A | 3796 | §103§112 | Final Rejection | 3d overdue | Pending | Jul 19, 2024 |
| 18754715 | METHODS FOR THE PROGNOSIS AND TREATMENT OF TEMPORAL LOBE EPILEPSY | PRIEST, AARON A | 1681 | §101§112 | Non-Final OA | — | Pending | Jun 26, 2024 |
| 18724159 | SOLAR HOT AIR BALLOON VENT | XAVIER, VALENTINA | 3642 | §103 | Final Rejection | 14d | Pending | Jun 25, 2024 |
| 18719497 | DUST SUPPRESSANT COMPOSITION COMPRISING GLYCOLIPID | KUMAR, PREETI | 1761 | §102§103 | Non-Final OA | — | Pending | Jun 13, 2024 |
| 18718521 | SGK1 INHIBITORY COMPOSITIONS AND METHODS | PAGUIO FRISING, MICHELLE F | 1651 | §103Other | Non-Final OA | — | Pending | Jun 11, 2024 |
| 18667395 | ANORECTAL TONOMETER FOR NEUROLOGICAL TESTING | BERHANU, ETSUB D | 3791 | §103§112 | Final Rejection | — | Pending | May 17, 2024 |
| 18708126 | COMPOSITION CONTAINING 3-HYDROXYANTHRANILIC ACID AND COMPOUNDS THAT ALTER IRON HOMEOSTASIS AND METHOD OF ITS USE | JOSEPH, JANET | 1611 | §101§102§103§112 | Non-Final OA | — | Pending | May 07, 2024 |
| 18615917 | USE OF A DISPERSIVE OPTICAL ELEMENT AS A SPECTRAL RECOMBINER FOR AN ADVANCED VOLUME HOLOGRAM FILTER (AVHF) AND OPTICAL IMAGING SYSTEMS EMPLOYING SUCH FILTER | LEE, MATTHEW Y | 2872 | §102§103 | Non-Final OA | 21d | Pending | Mar 25, 2024 |
| 18598889 | FLAME RETARDANT POLYMERS AND PROCESSES FOR PRODUCING AND USING THE SAME | SHI, GERARD ZHIHAO | 1765 | §102§103§112 | Non-Final OA | — | Pending | Mar 07, 2024 |
| 18686950 | COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS | VALLE, ERNESTO | 1623 | §103§112DP | Non-Final OA | — | Pending | Feb 27, 2024 |
| 18683189 | SAFE SELF-TESTING OF MULTIPLEX BIOMARKERS IN BIOFLUIDS | ABEL, LENORA A | 1799 | §103§112 | Non-Final OA | — | Pending | Feb 12, 2024 |
| 18294371 | ACTIVE TISSUE SCAFFOLD STRETCHING UNDER CELL CULTURE CONDITIONS | YOH, JULIUS FRANCIS | 1653 | §103 | Non-Final OA | — | Pending | Feb 01, 2024 |
| 18574777 | ENGINEERED NODAVIRAL CARGO DELIVERY SYSTEMS | MARVICH, MARIA | 1634 | §112 | Non-Final OA | — | Pending | Dec 28, 2023 |
| 18530028 | GLYCOPEPTIDES AND USES THEREOF | WANG, CHANG YU | 1658 | §102§103§112 | Non-Final OA | — | Pending | Dec 05, 2023 |
| 18566935 | BENCH-STABLE TRIAZENE COMPOSITIONS FOR PROTEIN MODIFICATION | ROGERS, JAMES WILLIAM | 1618 | §102§112Other | Non-Final OA | — | Pending | Dec 04, 2023 |
| 18560349 | METHOD OF TARGETED MULTI-PANEL APPROACH AND TIERED A.I. USE FOR DIFFERENTIAL DIAGNOSIS AND PROGNOSIS | VASSELL, MEREDITH ABBOTT | 1687 | §101§103§112 | Non-Final OA | — | Pending | Nov 10, 2023 |
| 18287427 | COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS THROUGH INHIBITION OF CD44 AND FERM PROTEIN INTERACTION | KIM, SEONG JONG | 1621 | §102§112 | Non-Final OA | 26d | Pending | Oct 18, 2023 |
| 18285876 | ISOTHERMAL AMPLIFICATION-BASED DETECTION OF SHRIMP PATHOGENS | GOLDBERG, JEANINE ANNE | 1682 | §103 | Final Rejection | 26d | Pending | Oct 06, 2023 |
| 18285971 | COMPOSITIONS AND METHODS FOR DELIVERING PHARMACEUTICAL AGENTS | SHOMER, ISAAC | 1612 | §112 | Final Rejection | — | Pending | Oct 06, 2023 |
| 18551727 | METHODS, SYSTEMS AND DEVICES FOR MODULATING CENTRAL NERVOUS SYSTEM INFLAMMATION AND POST-OPERATIVE PAIN | CHRISTIANSON, SKYLAR LINDSEY | 3792 | §102§103 | Final Rejection | — | Pending | Sep 21, 2023 |
| 18549335 | DEVELOPMENT OF APTAMERS FOR NEUTRALIZING ANTIBODIES IN DEMYELINATING DISEASES | JOHNSON, TIRONE DEREK | 1675 | §102§103§112 | Non-Final OA | — | Pending | Sep 06, 2023 |
| 18273102 | ROBOTICALLY APPLIED 3D-SPRAYABLE EXTERIOR INSULATION AND FINISH SYSTEMS (EIFS) FOR BUILDING ENVELOPE RETROFITS | TUROCY, DAVID P | 1718 | §103 | Non-Final OA | — | Pending | Jul 19, 2023 |
| 18269021 | COMPOSITIONS AND METHODS FOR CONTROLLING PSYLLIDS | ORDAZ, CHRISTIAN JOSE | 1663 | §102§103§112Other | Non-Final OA | — | Pending | Jun 22, 2023 |
| 18265335 | COMPOSITIONS AND METHODS FOR INHIBITING M PRO PROTEASE ACTIVITY AND FOR PREVENTING AND TREATING SARS-COV-2 INFECTION | DAHLIN, HEATHER RAQUEL | 1629 | §102§112 | Final Rejection | 23d overdue | Pending | Jun 05, 2023 |
| 18254068 | IMMUNOGENIC NANOVESICLES FOR CANCER IMMUNOTHERAPY | MURESAN, ANA Z | 1692 | §102§112 | Non-Final OA | — | Pending | May 23, 2023 |
| 18253891 | COMPOSITIONS AND METHODS FOR BLOCKING NEUROPILIN RECEPTOR 1 FOR THE TREATMENT OF PAIN AND PREVENTION OF VIRAL ENTRY | VISHNYAKOVA, ELENA VLADIMIROVNA | 1691 | §103 | Final Rejection | 19d | Pending | May 22, 2023 |
| 18037098 | VIBRIO TOXIN BINDING PROTEINS IN SHRIMP AND USES THEREOF | STEELE, AMBER D | 1658 | §101§103§112 | Final Rejection | 3d overdue | Pending | May 16, 2023 |
| 18035134 | COMPOSITIONS AND METHODS FOR SCREENING PESTICIDES | DAVIS, RUTH A | 1699 | §101§102§112Other | Final Rejection | — | Pending | May 03, 2023 |
| 18251078 | COMPOSITIONS AND METHODS OF TREATING INFLAMMATORY LUNG DISEASES | BEANE, RANDALL L | 1654 | §102§112 | Non-Final OA | 55d | Pending | Apr 28, 2023 |
| 18028305 | GALLBLADDER CRYOABLATION DEVICE AND METHOD | FLANAGAN, BEVERLY MEINDL | 3794 | §102§112 | Final Rejection | 1d overdue | Pending | Mar 24, 2023 |
| 18044344 | BIOSENSOR FOR DETECTING STRUCTURAL CHANGES IN HUMAN CARDIAC MUSCLE PROTEIN | IVICH, FERNANDO NMN | 1600 | §103§112 | Final Rejection | — | Pending | Mar 07, 2023 |
| 18043694 | SOLAR TOWER TO DRY ORGANIC MATTER ON A LARGE SCALE | LAU, JASON | 3762 | §103 | Non-Final OA | 70d | Pending | Mar 01, 2023 |
| 18174158 | METHODS, SYSTEMS, AND COMPOSITIONS FOR LEGUME-BASED PRODUCTION OF THERAPEUTIC PROTEINS AND THERAPEUTIC MEDICAL MATERIALS | HA, JULIE | 1654 | §101§102§103§112 | Non-Final OA | 22d | Pending | Feb 24, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialArizona Board of Regents on Behalf of the University of Arizona has 70 pending office actions as of October 2026, spread across 51 art units and 69 examiners.
Preeti Kumar has the most, with 2 of Arizona Board of Regents on Behalf of the University of Arizona's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.